Stephen Brady promoted to chief business officer at 3-V
This article was originally published in Scrip
Executive Summary
3-V Biosciences, a Menlo Park, California-based biopharmaceutical company focused on the discovery, development and commercialisation of therapeutics that target host cell factors required for infection, has promoted Stephen Brady to chief business officer. Mr Brady joined the company last year as vice-president of corporate development, strategy and operations, having previously served as vice-president of corporate development at Proteolix.